Swedish guidelines on the management of community-acquired pneumonia in immunocompetent adults—Swedish Society of Infectious Diseases 2012

Autor:	Lars Eriksson, Anna Nilsson, Jonas Hedlund, Christer Lidman, Gunilla Hjerdt-Goscinski, Hans Holmberg, Kristoffer Strålin, Åke Örtqvist, Carl Spindler
Rok vydání:	2012
Předmět:	Adult Microbiological Techniques Microbiology (medical) medicine.medical_specialty Cefotaxime medicine.drug_class Antibiotics medicine.disease_cause Decision Support Techniques Pharmacotherapy Antibiotic resistance Community-acquired pneumonia Streptococcus pneumoniae medicine Humans Intensive care medicine Sweden General Immunology and Microbiology business.industry Pneumonia General Medicine medicine.disease Anti-Bacterial Agents Community-Acquired Infections Penicillin Infectious Diseases Drug Therapy Combination business medicine.drug
Zdroj:	Scandinavian Journal of Infectious Diseases. 44:885-902
ISSN:	1651-1980 0036-5548
DOI:	10.3109/00365548.2012.700120
Popis:	This document presents the 2012 evidence based guidelines of the Swedish Society of Infectious Diseases for the in- hospital management of adult immunocompetent patients with community-acquired pneumonia (CAP). The prognostic score 'CRB-65' is recommended for the initial assessment of all CAP patients, and should be regarded as an aid for decision-making concerning the level of care required, microbiological investigation, and antibiotic treatment. Due to the favourable antibiotic resistance situation in Sweden, an initial narrow-spectrum antibiotic treatment primarily directed at Streptococcus pneumoniae is recommended in most situations. The recommended treatment for patients with severe CAP (CRB-65 score 2) is penicillin G in most situations. In critically ill patients (CRB-65 score 3-4), combination therapy with cefotaxime/macrolide or penicillin G/fluoroquinolone is recommended. A thorough microbiological investigation should be undertaken in all patients, including blood cultures, respiratory tract sampling, and urine antigens, with the addition of extensive sampling for more uncommon respiratory pathogens in the case of severe disease. Recommended measures for the prevention of CAP include vaccination for influenza and pneumococci, as well as smoking cessation.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb3f10606712a23697dbe502156681fe https://doi.org/10.3109/00365548.2012.700120 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.